Ameriprise Financial Inc Mustang Bio, Inc. Transaction History

Ameriprise Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.46 - $7.2 $13,760 - $215,388	-29,915 Reduced 64.17%	16,700 $8,000
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $10,895 - $21,227	-18,785 Reduced 28.72%	46,615 $27,000
Q1 2022 May 16, 2022	BUY	$0.73 - $1.81 $9,490 - $23,530	13,000 Added 24.81%	65,400 $66,000
Q4 2021 Feb 14, 2022	SELL	$1.66 - $2.64 $45,816 - $72,864	-27,600 Reduced 34.5%	52,400 $87,000
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $5,160 - $6,720	-2,000 Reduced 2.44%	80,000 $215,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $6,210 - $8,763	2,300 Added 2.89%	82,000 $272,000
Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $153,718 - $262,644	50,900 Added 176.74%	79,700 $265,000
Q4 2020 Feb 12, 2021	BUY	$2.66 - $4.18 $76,608 - $120,383	28,800 New	28,800 $103,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.